IL22 and colitis: HQD could alleviate DSS-induced colitis through microbiota-derived indoles that activate AhR and, directly or via IL-22, drive ISC differentiation; however, this attractive mechanistic framework is not unique to HQD—probiotics or synthetic AhR agonists can exploit the same pathway.